Últimos Artículos de Diabetes, Obesity and Metabolism
- The SGLT2i Treatment Gap in UK Primary Care: A Cross‐Sectional RWE Study of Prescribing in Clinical Practice
- Efficacy and Safety of Glucagon‐Like Peptide‐1 Receptor Agonists as Adjuncts to Insulin Therapy in Type 1 Diabetes Mellitus: An Overlap‐Informed Umbrella Review
- Alcohol Reduction and 15‐Year Cardiometabolic Changes in Glycemic, Lipid and Blood Pressure Profiles: A Target Trial Emulation Study
- Dose‐Normalised Time in Range (dn‐TIR) Improves Following Hybrid Closed‐Loop (HCL) Therapy in Type 1 Diabetes: A Real‐World Cohort Study From Australia and the United Kingdom
- Residual Apolipoprotein B Elevation Despite PREVENT‐Guided LDL‐C Goal Attainment Among Adults Without Known ASCVD
- Renal Safety of Intravitreal Ranibizumab and the Effects of SGLT2 Inhibition in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial
- Weight Loss Is Not Surgical Readiness: The Missing Operative Phenotype in GLP‐1 Body‐Composition Assessment
- Antenatal Corticosteroids in Gestational Diabetes: A Systematic Review of Glycemic Response and Management Strategies
- Glucagon‐Like Peptide‐1 Medicines and Risk of Dysaesthesia: A Systematic Review, Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials
- Real‐World Adoption of Generative AI for Carbohydrate Counting in Adults With Type 1 Diabetes
- Beyond Weight Loss: The Challenge of Stopping Obesity Management Medications
- GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics
- Urban Burden Index–Multidomain Assessment of Integrated Obesogenic Risk (UBI‐MAIOR) and Obesity Prevalence Across 10 Metropolitan Areas: An Exploratory Pilot Analysis
- SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Fabry Disease: Observations From a Federated Research Network
- Association of GLP‐1 Receptor Agonists Versus Other Antidiabetic Medications With Cardiovascular, Renal, and Liver Outcomes in Patients With Type 2 Diabetes
- Glucagon‐Like Peptide‐1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis‐Related Diabetes
- A Multicentre Study of Prevalence and Risk Factors of Diabetic Retinopathy in Children and Young People With Type 1 Diabetes in the United Kingdom
- Genome‐Wide Association Analyses Identify Distinct Genetic Architectures for Extreme Early‐Onset and Late‐Onset T2D
- Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study
- A Biweekly GLP‐1R Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability